Skip to content
DataLookout
Menu

NCT06023134

Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart Failure

StatusActive, Not Recruiting
PhaseNot specified
SponsorJingyi Ren
Primary completion (estimated)

At risk: Primary completion moved 2 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 2 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Sep 1, 2025 to Sep 1, 2027
    • Eligibility criteria expanded, about 8 words
    • Study completion pushed from Dec 1, 2025 to Dec 1, 2027
    • Secondary endpoints: details revised at 2 of 11 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Time to first event of adjudicated CV death mortality or adjudicated HHF
Timeframe: 24 weeks

Secondary (11)

Occurrence of adjudicated HHF (first and recurrent)
Time to adjudicated CV death
Time to all-cause mortality
Time to first all-cause hospitalisation
Composite of time to first event of all-cause mortality and all cause hospitalisation
Show 6 moreShow less
Change in NYHA class from baseline at week 24
Changes in N-terminal Pro-brain Natriuretic Peptide (NT-proBNP) from baseline over time
Change in liver functions from baseline over time
Change in renal function from baseline over time
Change in echocardiographic data from baseline over time
Change in ECG data from baseline over time

Arms and interventions

Control group

Participants met the indication for right heart catheterization but did not meet the diagnostic criteria for pulmonary hypertension and right heart failure.

Pulmonary Hypertension group

Participants were classified according to the 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension, meaning that a mean pulmonary artery pressure (mPAP) ≥20 mmHg was defined as PH.

Right heart failure group

Right heart failure was considered present when RV fractional area change (FAC) was \<35% or tricuspid annular systolic velocity (RV S') was \<9.5 cm/s or tricuspid annular plane systolic excursion (TAPSE) \<17mm.

Diagnostic tests: Echocardiography, Right heart catheterization

Sites

1 site in 1 country

  • China-Japan Friendship HospitalBeijing, Beijing Municipality, China